Brian R. Mueller is the Executive Vice President, Finance and Chief Financial Officer (CFO) at BioMarin Pharmaceutical Inc., a global biotechnology company focused on developing and commercializing innovative therapies for serious and life-threatening rare genetic diseases. Mueller joined BioMarin in 2012 and has been instrumental in steering the company's financial strategy, ensuring its growth and sustainability in a highly competitive industry. Prior to joining BioMarin, Mueller held several high-level finance positions at notable companies. He served as CFO at a leading medical device company, where he played a pivotal role in driving the company's financial performance and strategic initiatives. Earlier in his career, Mueller worked at a major pharmaceutical company, gaining extensive experience in financial planning, analysis, and management. His diverse background in both the medical device and pharmaceutical sectors has equipped him with a unique perspective and skill set, enabling him to effectively manage BioMarin's financial operations. As CFO at BioMarin, Mueller is responsible for overseeing the company's global finance functions, including financial planning and analysis, accounting, tax, treasury, and investor relations. Under his leadership, BioMarin has achieved significant milestones, such as the successful launch of new therapies and the expansion of its product portfolio. Mueller's strategic vision and financial acumen have been crucial in securing the company's position as a leader in the rare disease market, while also ensuring its long-term financial health and growth.